Core Viewpoint - AbbVie plans to invest $380 million to build two new active pharmaceutical ingredient production facilities in Illinois, USA, to expand its domestic production capacity for neuroscience and weight loss drugs [1] Group 1: Investment Details - The investment of $380 million will be directed towards the construction of new production facilities [1] - AbbVie already operates 11 production sites in the United States [1] - The company is in discussions with multiple states regarding potential projects and expects to announce further investments this year [1]